Misappropriation of Controlled Medications by Agency RN During Night Shift
Summary
The deficiency involves the facility’s failure to protect several residents from misappropriation of their medications, specifically controlled substances and other drugs. Multiple residents with intact cognition and orders for pain medications, including opioids and gabapentin, were affected. One resident with rheumatoid arthritis, chronic pain, and COPD had an order for scheduled oxycodone; another resident with COPD, diabetes, and morbid obesity had an as-needed oxycodone order; a third resident with schizophrenia and phantom limb pain had an order for gabapentin; a fourth resident with arthritis and muscle wasting also had an order for gabapentin; and a fifth resident with osteomyelitis and rheumatoid arthritis had an as-needed oxycodone order. At the time of later interviews, the cognitively intact residents reported they were unaware of any misappropriation and felt their pain was well managed, but records showed that their medications had been misappropriated. The events leading to the deficiency centered on a night shift during which an agency RN was the only nurse assigned to one side of the building, with an agency LPN assigned to the other side. Pharmacy delivery records showed that oxycodone tablets had been delivered for two residents, but the corresponding Individual Patient Controlled Substance Administration Records for those medications were missing. During the 7:00 p.m. to 7:00 a.m. shift, the agency RN documented wasting oxycodone tablets for two former residents, with cosignature initials that the facility later determined did not match any staff on duty. The next morning, during shift-to-shift controlled substance counts, the agency RN reported that she had dropped all the controlled substance cards and that another nurse had helped her reorganize them. Witness statements from oncoming LPNs described that the agency RN attempted to have them clock her out on the agency app before report, stated that the cards had been dropped and reorganized, and then completed a count that initially appeared correct. Within minutes after the agency RN left, the oncoming LPNs recounted the controlled substances and discovered discrepancies. A full card of oxycodone for one resident and four oxycodone tablets for another resident were missing, along with the associated count sheets. Additional review showed that a card of oxycodone signed into the cart two days earlier was no longer present and not documented as removed, and that some controlled substances were documented as wasted with unrecognizable cosignature initials. Further investigation revealed that two cards of gabapentin for one resident and one card of gabapentin for another resident were also missing. The agency LPN who was alleged to have assisted with reorganizing the cards denied ever going to the other side or wasting medications with the agency RN. Facility staff, including the MDS nurse and DON, confirmed that multiple oxycodone tablets and gabapentin cards for the identified residents were missing and that the documentation of wasting and cosigning did not match any staff who had worked during the relevant shift. The facility’s abuse, neglect, exploitation, or misappropriation policy addressed reporting requirements but did not contain language stating that residents were to remain free from misappropriation, and the misappropriation of medications was determined to have occurred prior to the survey.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.